2015 GLOBAL OPPORTUNITIES IN INTERVENTIONAL ACUTE STROKE THERAPIES

200 Pages | 2015 Analysis | Forecasts Through 2019

OVERVIEW:
The report covers emerging and existing neurointerventional technologies used in the management of patients with intracranial hemorrhage and acute cerebral ischemia. Special emphasis is given to novel left atrial appendage systems for the prevention of cardiogenic stroke (which accounts for about 20% of all acute ischemic stroke cases), and cerebral thrombectomy systems that address a large unmet need in the emergent treatment of acute ischemic stroke patients (less than 5% of the latter qualify for marginally efficacious intravenous tPA therapy, the only modality currently approved as the first line treatment regimen for acute cerebral ischemia). The report also covers established interventional modalities for prophylaxis of hemorrhagic and ischemic stroke, including endovascular embolization systems targeting cerebral aneurysms and arteriovenous malformations and carotid stenting systems and their accompanying embolic protection devices, used for the prevention of catastrophic cerebrovascular events in patients with high grade carotid stenosis.

Epidemiological, procedure and market data are presented for four market geographies, including the United States, Major Europe (the five largest Western European States), Major Asia-Pacific (encompassing China, India and Japan), and Rest of the World nations. The report projections are based on detailed, clinical and econometric models for the years 2013 through 2019 that are intended to act as a working tool for clients of the report. They provide dynamic models of the covered technologies' utilization patterns and revenue growth within the context of neurointerventional radiology practices in the targeted regions, historic analogies of adoption of similar transcatheter tools and techniques, priorities in local healthcare policies, and the availability of funding, among other factors.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

1. Epidemiology and Patients

1.1 Hemorrhagic Stroke
	1.1.1 Intracerebral Hemorrhage (ICH)
		1.1.1.1	Causes, Risk Factors and Symptoms
		1.1.1.2 Incidence and Patients by Major Geography
		1.1.1.3	Treatment of Acute ICH
	1.1.2 Subarachnoid Hemorrhage (SAH)
		1.1.2.1	Causes, Risk Factors and Symptoms
		1.1.2.2	Incidence and Patients by Major Geography 
		1.1.2.3	Treatment of Acute SAH
	1.1.3 Cerebral Aneurysms, Arteriovenous Malformations and Hemorrhagic Stroke 	
1.2 Ischemic Stroke
	1.2.1 Thrombotic Stroke - Causes & Mechanisms	
	1.2.2 Embolic Stroke - Causes & Mechanisms
	1.2.3 Hypoperfusion Stroke - Causes & Mechanisms
	1.2.4 Symptoms and Risk Factors for Ischemic Stroke
	1.2.5 Incidence and Patients by Major Geography
	1.2.6 Treatment of Acute Ischemic Stroke

2. Interventional Tools and Techniques for Acute Stroke Management

2.1 Prophylaxis of Hemorrhagic Stroke
	2.1.1 Treatment of Cerebral Aneurysms and AVMs
		2.1.1.1	Embolization Technologies
			2.1.1.1.1  Microcoil Systems
			2.1.1.1.2  Liquid Embolic Systems
			2.1.1.1.3  Embolization Enabling Stenting Systems
			2.1.1.1.4  Cerebral Embolization Procedure Volumes
2.2 Prophylaxis and Treatment of Acute Ischemic Stroke		
	2.2.1 Carotid Artery Stenting (CAS)
		2.2.1.1	Stenting versus Endarterectomy
		2.2.1.2	CAS Systems
		2.2.1.3	Embolic Protection Devices
		2.2.1.4	CAS Procedure Volumes
	2.2.2 Left Atrial Appendage (LAA) Closure 
		2.2.2.1	LAA Closure Technologies
		2.2.2.2	LAA Closure Procedure Volumes
	2.2.3 Cerebral Thrombectomy 
		2.2.3.1	Cerebral Thrombectomy Devices 
		2.2.3.2	Cerebral Thrombectomy Procedure Volumes
	2.2.4 Intracranial Stenting 
		2.2.4.1	Intracranial Stenting Technologies
		2.2.4.2	Intracranial Stenting Procedure Volumes

3. Global Markets for Interventional Acute Stroke Therapies
	
3.1 Cerebral Aneurysm and AVM Embolization Systems
	3.1.1 Market Forecast by Major Geography
	3.1.2 Competitive Analysis
3.2 Carotid Stenting Systems and Embolic Protection Devices
	3.2.1 Market Forecast by Major Geography
	3.2.2 Competitive Analysis
3.3 Left Atrial Appendage Closure Systems
	3.3.1 Market Forecast by Major Geography
	3.3.2 Competitive Analysis
3.4 Cerebral Thrombectomy Systems
	3.4.1 Market Forecast by Major Geography
	3.4.2 Competitive Analysis
3.5 Intracranial Stenting Systems
	3.5.1 Market Forecast by Major Geography
	3.5.2 Competitive Analysis

4. Company Profiles
 
4.1 Aachen Resonance
4.2 Abbott Vascular (Abbott Laboratories)
4.3 Acandis
4.4 Atricure
4.5 Bard Peripheral Vascular (C.R. Bard)
4.6 Boston Scientific
4.7 Codman/DePuy Synthes (Johnson & Johnson)
4.8 Medtronic/Covidien
4.9 MicroVention (Terumo)
4.10 Neuravi
4.11 Penumbra
4.12 Phenox
4.13 St. Jude Medical
4.14 Stryker

5. Major Country/Regional Profiles

5.1 United States
5.2 Major Europe
	5.2.1 France
	5.2.2 Germany
	5.2.3 Italy
	5.2.4 Spain
	5.2.5 United Kingdom
5.3 Major Asia-Pacific
	5.3.1 China
	5.3.2 India
	5.3.3 Japan


COMPANIES COVERED:

  1. Aachen Resonance
  2. Abbott Vascular (Abbott Laboratories)
  3. Acandis
  4. Atricure
  5. Bard Peripheral Vascular (C.R. Bard)
  6. Boston Scientific
  7. Codman/DePuy Synthes (Johnson & Johnson)
  8. Medtronic/Covidien
  9. MicroVention (Terumo)
  10. Neuravi
  11. Penumbra
  12. Phenox
  13. St. Jude Medical
  14. Stryker
Contact Us

Need help finding medtech research? Let us help you!